Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants (Q38704288)

30 June 2019

meta-analysis

0 references

review article

1 reference

title

Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants. (English)

1 reference

30 June 2019

necrotizing enterocolitis

main subject

preterm infant

0 references

sepsis

0 references

1 reference

Mohan Pammi

1

1 reference

30 June 2019

Gautham Suresh

series ordinal

2

1 reference

30 June 2019

publication date

28 June 2017

1 reference

30 June 2019

Cochrane Database of Systematic Reviews

published in

1 reference

30 June 2019

volume

6

1 reference

30 June 2019

page(s)

CD007137

1 reference

30 June 2019

Oral lactoferrin to prevent nosocomial sepsis and necrotizing enterocolitis of premature neonates and effect on T-regulatory cells

cites work

1 reference

https://api.crossref.org/works/10.1002/14651858.CD007137.PUB5

The Lacuna Trial: a double-blind randomized controlled pilot trial of lactoferrin supplementation in the very preterm infant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD007137.PUB5

Efficacy of Bovine Lactoferrin Supplementation in Preventing Late-onset Sepsis in low Birth Weight Neonates: A Randomized Placebo-Controlled Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD007137.PUB5

Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD007137.PUB5

Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD007137.PUB5

Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD007137.PUB5

Randomized controlled trial of lactoferrin for prevention of sepsis in peruvian neonates less than 2500 g.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD007137.PUB5

Randomized Controlled Trial of Talactoferrin Oral Solution in Preterm Infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD007137.PUB5

Randomized double-blind controlled trial of bovine lactoferrin for prevention of diarrhea in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD007137.PUB5

Neonatal infection and long-term neurodevelopmental outcome in the preterm infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD007137.PUB5

Probiotics for prevention of necrotizing enterocolitis in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD007137.PUB5

Enhanced clearance of Escherichia coli and Staphylococcus aureus in mice treated with cyclophosphamide and lactoferrin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD007137.PUB5

Glycosylation of human milk lactoferrin exhibits dynamic changes during early lactation enhancing its role in pathogenic bacteria-host interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD007137.PUB5

Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD007137.PUB5

Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD007137.PUB5

The Role of Nuclear Factor- κ B in Cytokine Gene Regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD007137.PUB5

Prebiotic effects of bovine lactoferrin on specific probiotic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD007137.PUB5

The "Golden Age" of Probiotics: A Systematic Review and Meta-Analysis of Randomized and Observational Studies in Preterm Infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD007137.PUB5

Lactoferricin: a lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD007137.PUB5

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD007137.PUB5

Lactoferrin inhibits hepatitis C virus viremia in chronic hepatitis C patients with high viral loads and HCV genotype 1b.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD007137.PUB5

Estimating the causes of 4 million neonatal deaths in the year 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD007137.PUB5

Overview of Lactoferrin as a Natural Immune Modulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD007137.PUB5

Antimicrobial resistance: bacteria on the defence. Resistance stems from misguided efforts to try to sterilise our environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD007137.PUB5

Necrotising enterocolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD007137.PUB5

Lactoferrin and the newborn: current perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD007137.PUB5

Clinical Benefits of Lactoferrin for Infants and Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD007137.PUB5

Molecular aspects of intestinal epithelial cell-bacterial interactions that determine the development of intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD007137.PUB5

Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibiotic-resistant bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD007137.PUB5

Lactoferrin and prematurity: a promising milk protein?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD007137.PUB5

Molecular cloning and sequence analysis of bovine lactotransferrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD007137.PUB5

Inflammatory mechanisms in neonatal chronic lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD007137.PUB5

Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD007137.PUB5

Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD007137.PUB5

Very low birth weight preterm infants with early onset neonatal sepsis: the predominance of gram-negative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network, 2002-2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD007137.PUB5

Lactoferrin inhibits hepatitis C virus viremia in patients with chronic hepatitis C: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD007137.PUB5

Influence of bovine lactoferrin on selected probiotic bacteria and intestinal pathogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD007137.PUB5

Lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD007137.PUB5

Bovine lactoferrin and lactoferricin derived from milk: production and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD007137.PUB5

Antibacterial prophylaxis with lactoferrin in neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD007137.PUB5

Lactoferrin for prevention of neonatal sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD007137.PUB5

Lactoferrin: an important host defence against microbial and viral attack.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD007137.PUB5

Hospital-acquired neonatal infections in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD007137.PUB5

Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD007137.PUB5

Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD007137.PUB5

Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD007137.PUB5

Lactoferrin increases the susceptibility of S. epidermidis biofilms to lysozyme and vancomycin

21 January 2018

1 reference

12 December 2020

Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates

1 reference

12 December 2020

Lactoferrin protects neonatal rats from gut-related systemic infection

1 reference

12 December 2020

Phase I trial of oral talactoferrin alfa in refractory solid tumors

1 reference

12 December 2020

A double-blind, placebo-controlled, pilot study of bovine lactoferrin supplementation in bottle-fed infants

1 reference

12 December 2020

Lactoferrin induces concentration-dependent functional modulation of intestinal proliferation and differentiation

1 reference

12 December 2020

Prophylaxis with lactoferrin, a novel antimicrobial agent, in a neonatal rat model of coinfection

1 reference

12 December 2020

Lactoferrin can protect mice against a lethal dose of Escherichia coli in experimental infection in vivo

1 reference

12 December 2020

10.1002/14651858.CD007137.PUB5

Identifiers

DOI

1 reference

30 June 2019

PMC publication ID

6481465

1 reference

30 June 2019

PubMed publication ID

28658720

1 reference

30 June 2019